Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.26 | N/A |
| PEG Ratio (TTM) | 3.97 | N/A |
| P/S Ratio (TTM) | 2.09 | N/A |
| P/B Ratio (TTM) | 1.15 | N/A |
| P/FCF Ratio (TTM) | 10.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.95 | N/A |
| Price to 5YR AVG FCF Ratio | 9.50 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.99% | N/A |
| ROE (TTM) | 10.49% | N/A |
| Net Profit Margin (TTM) | 18.33% | N/A |
| ROIC 5YR AVG | 12.77% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.19% | 13.77% | 5.29% |
| Revenue | 12.05% | 3.94% | 4.15% |
| Net Income | 6.32% | 13.70% | 4.57% |
| Cash Flow | 1,051.88% | 23.57% | 18.61% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.46 | N/A |
| Interest Coverage (TTM) | 2.19 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.68 | N/A |
| LTL to 5YR AVG FCF | 1.94 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.74% | N/A |